162 related articles for article (PubMed ID: 33108684)
1. Hürthle cell lesions of the thyroid: Progress made and challenges remaining.
Wong KS; Angell TE; Barletta JA; Krane JF
Cancer Cytopathol; 2021 May; 129(5):347-362. PubMed ID: 33108684
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology-histology correlation.
Gilani SM; Ross JA; Prasad ML; Hammers L; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):363-373. PubMed ID: 33045146
[TBL] [Abstract][Full Text] [Related]
3. Challenges in Cytology Specimens With Hürthle Cells.
Thodou E; Canberk S; Schmitt F
Front Endocrinol (Lausanne); 2021; 12():701877. PubMed ID: 34248855
[TBL] [Abstract][Full Text] [Related]
4. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
5. Papillary Hürthle cell tumor of thyroid: report of a case with a cytomorphologic approach to diagnosis.
Dziecioł J; Musiatowicz B; Zimnoch L; Kemona A; Sulkowski S
Acta Cytol; 1996; 40(2):311-4. PubMed ID: 8629418
[TBL] [Abstract][Full Text] [Related]
6. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
Renshaw AA; Gould EW
Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
[TBL] [Abstract][Full Text] [Related]
7. Hürthle-cell neoplasms of the thyroid: An algorithmic approach to pathologic diagnosis in light of molecular advances.
Jalaly JB; Baloch ZW
Semin Diagn Pathol; 2020 Sep; 37(5):234-242. PubMed ID: 32444244
[TBL] [Abstract][Full Text] [Related]
8. PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression.
Cerutti JM; Oler G; Delcelo R; Gerardt R; Michaluart P; de Souza SJ; Galante PA; Huang P; Riggins GJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):E151-60. PubMed ID: 20926528
[TBL] [Abstract][Full Text] [Related]
9. Unraveling Hürthle cell lesions of the thyroid using molecular findings.
Wong KS
Cancer Cytopathol; 2022 Jun; 130(6):405-406. PubMed ID: 35285577
[No Abstract] [Full Text] [Related]
10. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
11. Granular-cell tumor of trachea masquerading as Hurthle-cell neoplasm on fine-needle aspirate: a case report.
Kintanar EB; Giordano TJ; Thompson NW; Michael CW
Diagn Cytopathol; 2000 Jun; 22(6):379-82. PubMed ID: 10820533
[TBL] [Abstract][Full Text] [Related]
12. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
Wong YP; Md Isa N; Md Zin RR; Noor Akmal S
Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms.
Troncone G; Volante M; Iaccarino A; Zeppa P; Cozzolino I; Malapelle U; Palmieri EA; Conzo G; Papotti M; Palombini L
Cancer; 2009 Dec; 117(6):522-9. PubMed ID: 19787802
[TBL] [Abstract][Full Text] [Related]
14. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
Máximo V; Sobrinho-Simões M
Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hürthle cell lesions by fine-needle aspiration.
Yang YJ; Khurana KK
Arch Pathol Lab Med; 2001 Aug; 125(8):1031-5. PubMed ID: 11473452
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy.
McKee S; Wu H; Wang X; Cramer H; Lin J; Chen S
Acta Cytol; 2014; 58(3):235-8. PubMed ID: 24819535
[TBL] [Abstract][Full Text] [Related]
17. Hürthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation.
Schatz-Siemers N; Brandler TC; Oweity T; Sun W; Hernandez A; Levine P
Diagn Cytopathol; 2019 Oct; 47(10):977-985. PubMed ID: 31293091
[TBL] [Abstract][Full Text] [Related]
18. CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
Li W; Xia S; Aronova A; Min IM; Verma A; Scognamiglio T; Gray KD; Ullmann TM; Liang H; Moore MD; Elemento O; Zarnegar R; Fahey TJ
J Surg Oncol; 2018 Nov; 118(6):1042-1049. PubMed ID: 30311656
[TBL] [Abstract][Full Text] [Related]
19. The oncocyte that went places: diagnosis with EUS-guided FNA.
Safdar Khan A; Crowe DR; Eloubeidi MA
Diagn Cytopathol; 2013 Nov; 41(11):977-9. PubMed ID: 21954063
[TBL] [Abstract][Full Text] [Related]
20. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
